Teva Pharmaceutical Industries Ltd. (TEVA)
37.49
-0.61
(-1.60%)
USD |
NYSE |
Aug 26, 09:38
Teva Pharmaceutical Industries Total Liabilities (Quarterly) : 32.10B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.10B |
| March 31, 2026 | 31.81B |
| December 31, 2025 | 32.83B |
| September 30, 2025 | 32.60B |
| June 30, 2025 | 33.30B |
| March 31, 2025 | 32.15B |
| December 31, 2024 | 33.61B |
| September 30, 2024 | 35.37B |
| June 30, 2024 | 34.77B |
| March 31, 2024 | 35.23B |
| December 31, 2023 | 35.35B |
| September 30, 2023 | 34.58B |
| June 30, 2023 | 35.39B |
| March 31, 2023 | 34.84B |
| December 31, 2022 | 35.41B |
| September 30, 2022 | 34.73B |
| June 30, 2022 | 36.10B |
| March 31, 2022 | 36.80B |
| December 31, 2021 | 36.42B |
| September 30, 2021 | 36.40B |
| June 30, 2021 | 37.88B |
| March 31, 2021 | 38.03B |
| December 31, 2020 | 39.58B |
| September 30, 2020 | 39.14B |
| June 30, 2020 | 40.17B |
| Date | Value |
|---|---|
| March 31, 2020 | 40.74B |
| December 31, 2019 | 42.41B |
| September 30, 2019 | 42.32B |
| June 30, 2019 | 44.17B |
| March 31, 2019 | 44.03B |
| December 31, 2018 | 44.89B |
| September 30, 2018 | 45.93B |
| June 30, 2018 | 47.66B |
| March 31, 2018 | 49.08B |
| December 31, 2017 | 51.87B |
| September 30, 2017 | 55.79B |
| June 30, 2017 | 56.75B |
| March 31, 2017 | 55.53B |
| December 31, 2016 | 57.90B |
| September 30, 2016 | 61.72B |
| June 30, 2016 | 25.90B |
| March 31, 2016 | 24.53B |
| December 31, 2015 | 24.33B |
| September 30, 2015 | 25.72B |
| June 30, 2015 | 27.29B |
| March 31, 2015 | 24.27B |
| December 31, 2014 | 23.06B |
| September 30, 2014 | 22.94B |
| June 30, 2014 | 23.14B |
| March 31, 2014 | 23.86B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| Bristol Myers Squibb Co. | 65.32B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 27.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.86B |
| Shareholders Equity (Quarterly) | 7.753B |
| Debt to Equity Ratio | 2.176 |
| Current Ratio | 0.8795 |
| Net Debt Paydown Yield | 0.03% |